戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ventricular ejection fraction as measured by radionuclide ventriculography.
2 amine at 10 microg/kg/min, using equilibrium radionuclide ventriculography.
3 vasive hemodynamic monitoring and first-pass radionuclide ventriculography.
4 CG of 270 consecutive patients, referred for radionuclide ventriculography.
5 randomized patients had their EF measured by radionuclide ventriculography 5 years after study entry.
6                                              Radionuclide ventriculography and electrocardiographic (
7                                       Serial radionuclide ventriculography and endomyocardial biopsie
8 d strategy included noninvasive testing with radionuclide ventriculography and exercise thallium scin
9 t ventricular ejection fraction (measured by radionuclide ventriculography) and peak oxygen consumpti
10 ment monitoring, treadmill exercise testing, radionuclide ventriculography, and coronary angiography.
11 ic stress thallium scintigraphy and exercise radionuclide ventriculography are suboptimal screening t
12 valuation of Survival Trial measured LVEF by radionuclide ventriculography at baseline and at 3 and 1
13 educed systolic function, using quantitative radionuclide ventriculography at baseline, repeated afte
14 t with right-sided heart catheterization and radionuclide ventriculography at rest and during exercis
15 lobal and regional function were assessed by radionuclide ventriculography at rest and during two 5-m
16 t hemodynamics, gas exchange, and first-pass radionuclide ventriculography at rest and with cycle erg
17 eaking, and the Stroop test were measured by radionuclide ventriculography, ECG, and blood pressure a
18                  The LVEF was re-assessed by radionuclide ventriculography gated-blood pool (MUGA) sc
19 on concentrations were measured, and cardiac radionuclide ventriculography, Holter monitoring, and po
20 ary endpoint was change in LVEF, measured by radionuclide ventriculography, in hibernators versus non
21 11), myocardial function was determined with radionuclide ventriculography (n = 8), and myocardial ne
22 k filling) at rest and during exercise using radionuclide ventriculography, peak Vo(2), symptoms, qua
23            Thirty-five patients had exercise radionuclide ventriculography performed.
24 ic stress thallium scintigraphy and exercise radionuclide ventriculography performed; when either tes
25 has several potential advantages over planar radionuclide ventriculography (PRNV), including the poss
26 wo methods to measure ejection fraction (EF)-radionuclide ventriculography (RVG) and contrast left ve
27                              First-pass (FP) radionuclide ventriculography (RVG) and gated sestamibi
28  maximal-effort upright cycle ergometry with radionuclide ventriculography to determine rest and exer
29 meter LV catheter to obtain LV pressures and radionuclide ventriculography to obtain LV volumes durin
30 eft ventricular ejection fraction defined by radionuclide ventriculography was 24 +/- 2% (mean +/- SE
31                                              Radionuclide ventriculography was performed at baseline
32        Hemodynamic monitoring and first-pass radionuclide ventriculography were performed at rest and
33 esting with planar thallium scintigraphy and radionuclide ventriculography), where the use of coronar
34 ress thallium scintigraphy and also exercise radionuclide ventriculography with coronary angiography

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。